11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Don't miss the panel on Tackling Clinical Trial Execution Challenges with Intuitive and Flexible Technology
9 November 2023, 2:00 - 2:50PM ET in Monet 3
Clinical trials are becoming more complex and intelligently designed technology is more important than ever when it comes to supporting data integration, effective patient engagement, and improved time to insights. The burden on participants, sites and CROs/sponsors is significant, which is why it’s important to have strong collaboration among experts who know the clinical development space and are positioned to help solve unexpected problems that arise throughout a study. During this session, you’ll hear use cases from organizations that are addressing technology issues at various phases, therapeutic areas and levels of complexity with a unified clinical trials platform.
Presenters:
Jennifer Duff, General Manager, Zelta Clinical Trials Solutions
Nan Shao, EVP Global Operations, Veristat
Michelle Gayari, Executive Vice President, Global Operational Excellence and Innovation, MMS Holdings
With nearly 30 years of experience in clinical trial planning and execution for complex cancer therapies, Veristat is equipped to support any development program.
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
As a versatile scientific CRO and consultancy, we provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel cancer therapies. In the past five years, Veristat has supported more than 300 oncology studies and we have worked on more than 30 US and European regulatory marketing applications for cancer treatments.
Schedule A Meeting
If you would like to meet with a member of our team, please contact us through the form to arrange a meeting.
We are…Bold. Scientific. Versatile. Veristat.
Conference Details
Website: CNS Summit 2023
Schedule A Meeting
Meet with a member of the Veristat team:
8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...